22 Aug, 2016 12:08 PM
- NOX66 to extend reach from potentiating chemotherapy to potentiating radiotherapy
- Guidance to market on major program initiative.
As foreshadowed in the Company’s recent Prospectus, th...read more
10 Aug, 2016 09:06 AM
Noxopharm has completed putting in place the required logistics to enable it to conduct a clinical study of its lead pipeline drug candidate, NOX66, in Europe, commencing before the end of 2016.
Th...read more
09 Aug, 2016 11:00 AM
- Australian biotech with current focus on making standard frontline cancer chemotherapy work more effectively, in more cancers, and with less-damaging side-effects using innovative Australian technol...read more
05 Aug, 2016 02:20 PM
Noxopharm to list on ASX on Tuesday, 9th August 2016
ASX Ticker Code: NOX
Australian drug development company Noxopharm will begin trading on the ASX on Tuesday 9th August 2016 at 11 am ( AEST)...read more
